The Role of Pro-Resolving Lipid Mediators in Colorectal Cancer-Associated Inflammation: Implications for Therapeutic Strategies

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2020 Jul 30

PMID 32722560

Citations 5

Authors

Federica Ungaro

Silvia DAlessio

Silvio Danese

Affiliations

Soon will be listed here.

Abstract

Inflammation is a recognized hallmark of cancer that contributes to the development and progression of colorectal cancer (CRC). Anti-inflammatory drugs currently used for the treatment of CRC show many adverse side effects that prompted researchers to propose the polyunsaturated fatty acids-derived specialized pro-resolving mediators (SPMs) as promoters of resolution of cancer-associated inflammation. SPMs were found to inhibit the CRC-associated pro-inflammatory milieu via specific G-coupled protein receptors, although clinical data are still lacking. This review aims to summarize the state-of-the-art in this field, ultimately providing insights for the development of innovative anti-CRC therapies that promote the endogenous lipid-mediated resolution of CRC-associated inflammation.

Citing Articles

The Multifaceted Impact of Bioactive Lipids on Gut Health and Disease.

Sullivan J, Jones M Int J Mol Sci. 2025; 25(24.

PMID: 39769399 PMC: 11728145. DOI: 10.3390/ijms252413638.

The Impact of Resolution of Inflammation on Tumor Microenvironment: Exploring New Ways to Control Cancer Progression.

Liotti F, Marotta M, Melillo R, Prevete N Cancers (Basel). 2022; 14(14).

PMID: 35884394 PMC: 9316558. DOI: 10.3390/cancers14143333.

Probiotic Lactobacillus rhamnosus GG (LGG) restrains the angiogenic potential of colorectal carcinoma cells by activating a proresolving program via formyl peptide receptor 1.

Liotti F, Marotta M, Sorriento D, Pagliuca C, Caturano V, Mantova G Mol Oncol. 2022; 16(16):2959-2980.

PMID: 35808840 PMC: 9394235. DOI: 10.1002/1878-0261.13280.

Divergent Metabolic Effects of Metformin Merge to Enhance Eicosapentaenoic Acid Metabolism and Inhibit Ovarian Cancer In Vivo.

Udumula M, Poisson L, Dutta I, Tiwari N, Kim S, Chinna-Shankar J Cancers (Basel). 2022; 14(6).

PMID: 35326656 PMC: 8946838. DOI: 10.3390/cancers14061504.

Gut eukaryotic virome in colorectal carcinogenesis: Is that a trigger?.

Massimino L, Lovisa S, Lamparelli L, Danese S, Ungaro F Comput Struct Biotechnol J. 2020; 19:16-28.

PMID: 33363706 PMC: 7750180. DOI: 10.1016/j.csbj.2020.11.055.

References

Gupta R, DuBois R . Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer. 2002; 1(1):11-21. DOI: 10.1038/35094017. View

Le Gouvello S, Bastuji-Garin S, Aloulou N, Mansour H, Chaumette M, Berrehar F . High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas. Gut. 2007; 57(6):772-9. DOI: 10.1136/gut.2007.123794. View

Tacconi C, Correale C, Gandelli A, Spinelli A, Dejana E, DAlessio S . Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion. Gastroenterology. 2015; 148(7):1438-51.e8. DOI: 10.1053/j.gastro.2015.03.005. View

Wang W, Yang J, Nimiya Y, Lee K, Sanidad K, Qi W . ω-3 Polyunsaturated fatty acids and their cytochrome P450-derived metabolites suppress colorectal tumor development in mice. J Nutr Biochem. 2017; 48:29-35. PMC: 6278818. DOI: 10.1016/j.jnutbio.2017.06.006. View

Soehnlein O, Lindbom L . Phagocyte partnership during the onset and resolution of inflammation. Nat Rev Immunol. 2010; 10(6):427-39. DOI: 10.1038/nri2779. View

Blatner N, Mulcahy M, Dennis K, Scholtens D, Bentrem D, Phillips J . Expression of RORγt marks a pathogenic regulatory T cell subset in human colon cancer. Sci Transl Med. 2012; 4(164):164ra159. PMC: 3762575. DOI: 10.1126/scitranslmed.3004566. View

Villalba M, Evans S, Vidal-Vanaclocha F, Calvo A . Role of TGF-β in metastatic colon cancer: it is finally time for targeted therapy. Cell Tissue Res. 2017; 370(1):29-39. DOI: 10.1007/s00441-017-2633-9. View

Aglago E, Huybrechts I, Murphy N, Casagrande C, Nicolas G, Pischon T . Consumption of Fish and Long-chain n-3 Polyunsaturated Fatty Acids Is Associated With Reduced Risk of Colorectal Cancer in a Large European Cohort. Clin Gastroenterol Hepatol. 2019; 18(3):654-666.e6. DOI: 10.1016/j.cgh.2019.06.031. View

Bunt S, Yang L, Sinha P, Clements V, Leips J, Ostrand-Rosenberg S . Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression. Cancer Res. 2007; 67(20):10019-26. PMC: 4402704. DOI: 10.1158/0008-5472.CAN-07-2354. View

10.

Guzinska-Ustymowicz K, Kemona A . Transforming growth factor beta can be a parameter of aggressiveness of pT1 colorectal cancer. World J Gastroenterol. 2005; 11(8):1193-5. PMC: 4250712. DOI: 10.3748/wjg.v11.i8.1193. View

11.

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

12.

Qiu M, Hu J, Yang D, Cosgrove D, Xu R . Pattern of distant metastases in colorectal cancer: a SEER based study. Oncotarget. 2015; 6(36):38658-66. PMC: 4770727. DOI: 10.18632/oncotarget.6130. View

13.

Mariani F, Sena P, Roncucci L . Inflammatory pathways in the early steps of colorectal cancer development. World J Gastroenterol. 2014; 20(29):9716-31. PMC: 4123361. DOI: 10.3748/wjg.v20.i29.9716. View

14.

Hopkins M, Zhang Z, Liu Z, Meier K . Eicosopentaneoic Acid and Other Free Fatty Acid Receptor Agonists Inhibit Lysophosphatidic Acid- and Epidermal Growth Factor-Induced Proliferation of Human Breast Cancer Cells. J Clin Med. 2016; 5(2). PMC: 4773772. DOI: 10.3390/jcm5020016. View

15.

Dekker E, Tanis P, Vleugels J, Kasi P, Wallace M . Colorectal cancer. Lancet. 2019; 394(10207):1467-1480. DOI: 10.1016/S0140-6736(19)32319-0. View

16.

Tutino V, De Nunzio V, Caruso M, Veronese N, Lorusso D, Di Masi M . Elevated AA/EPA Ratio Represents an Inflammatory Biomarker in Tumor Tissue of Metastatic Colorectal Cancer Patients. Int J Mol Sci. 2019; 20(8). PMC: 6515168. DOI: 10.3390/ijms20082050. View

17.

Mobraten K, Haug T, Kleiveland C, Lea T . Omega-3 and omega-6 PUFAs induce the same GPR120-mediated signalling events, but with different kinetics and intensity in Caco-2 cells. Lipids Health Dis. 2013; 12:101. PMC: 3720243. DOI: 10.1186/1476-511X-12-101. View

18.

Erez N, Truitt M, Olson P, Arron S, Hanahan D . Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent Manner. Cancer Cell. 2010; 17(2):135-47. DOI: 10.1016/j.ccr.2009.12.041. View

19.

Barbalho S, de Alvares Goulart R, Quesada K, Bechara M, Carvalho A . Inflammatory bowel disease: can omega-3 fatty acids really help?. Ann Gastroenterol. 2016; 29(1):37-43. PMC: 4700845. View

20.

Bollrath J, Phesse T, von Burstin V, Putoczki T, Bennecke M, Bateman T . gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. Cancer Cell. 2009; 15(2):91-102. DOI: 10.1016/j.ccr.2009.01.002. View